Oppenheimer Lowers PT on InterMune to $38

Symbols: ITMN
Share

Oppenheimer has lowered the price target on InterMune (NASDAQ: ITMN) from $52 to $38 and maintains its Outperform rating.


 
 
< Previous
Morgan Stanley Initiates Intermolecular at Overweight
Next >
Oppenheimer Upgrades VOC Energy Trust to Outperform
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust